The document summarizes a report on the global companion animal veterinary vaccines market. It states that the market is expected to decline in 2020 due to the negative impacts of the COVID-19 pandemic, but recover and grow at a CAGR of 7.43% from 2020 to 2023. The report covers segments of the market by product type, including inactivated, live attenuated, and recombinant vaccines. It also covers segments by route of administration such as oral and parenteral vaccines. The major geographic regions analyzed in the report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
The document summarizes a report on the global companion animal veterinary vaccines market. It states that the market is expected to decline in 2020 due to the negative impacts of the COVID-19 pandemic, but recover and grow at a CAGR of 7.43% from 2020 to 2023. The report covers segments of the market by product type, including inactivated, live attenuated, and recombinant vaccines. It also covers segments by route of administration such as oral and parenteral vaccines. The major geographic regions analyzed in the report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
The document summarizes a report on the global companion animal veterinary vaccines market. It states that the market is expected to decline in 2020 due to the negative impacts of the COVID-19 pandemic, but recover and grow at a CAGR of 7.43% from 2020 to 2023. The report covers segments of the market by product type, including inactivated, live attenuated, and recombinant vaccines. It also covers segments by route of administration such as oral and parenteral vaccines. The major geographic regions analyzed in the report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
reserved. Companion Animal Veterinary Vaccines Market Characteristics: • The global companion animal veterinary vaccines market is expected to decline from $2.72 billion in 2019 to $2.60 billion in 2020 at a compound annual growth rate (CAGR) of -4.34%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $3.22 billion in 2023 at a CAGR of 7.43%. • The Business Research Company published its Companion Animal Veterinary Vaccines Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global Companion Animal Veterinary Vaccines market. The report provides in-depth analysis of the impact of COVID-19 on the market, along with revised market numbers due to the effects of the coronavirus. • The report covers the Companion Animal Veterinary Vaccines market’s segments- • 1) By Product: Inactivated, Live Attenuated, Recombinant, Others • 2) By Route Of Administration: Oral, Parenteral, Others • The major regions included in the report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.